24GUT540 : Meeting of Breast Cancer Patients and Pathologists
Part of paid clinical trials in Lebanon, New Hampshire.
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Study ID
- NCT07040514
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Questionnaires of Patient understanding of Pathologist input — OTHER* Benefit Self-Rating Total Score (assessing patient's perceptions of anticipated and actual extent to which they benefitted from the meeting with the pathologist) * Knowledge Questionnaire Total Score (assessing accuracy of knowledge of their own diagnosis and the diagnostic process in general) * State-Trait Anxiety Inventory Form Y (Total Scores for state (current) and trait (general) anxiety)
Study Details
Historically, most pathologists have had little direct contact or communication with patients. In the past two decades, however, there has been a modest movement toward patient-pathologist visits in which pathologists review with patients their pathology slides. Very few studies of such encounters have been conducted. Most surveyed patients reported that the experience was positive and helpful to them. Our basic goal is to determine if such meetings are useful to patients; a secondary goal is to determine if such encounters are useful to, and practical for, pathologists.
Key Dates
- Start date
- Jul 10, 2025
- Status verified
- Jul 2025
- Primary completion
- Jun 1, 2027
- Completion
- Jun 1, 2028
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Other: Assessment of Patient understanding of Pathologist inputAssessment of patient understanding of, and sense of control regarding, their disease, and their perception of the potential benefit of having pathologists on their medical team.
Primary Outcome Measure
Participant self-rating of understanding of, and empowerment in relation to, their disease, as measured using pre and post-visit knowledge questionnaires, and survey after meeting with a pathologist. [ Time Frame: 1-2 weeks ]
Central Contacts
- Research Nurse800-639-6918
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | - |
Find similar trials in Lebanon, NH
Related Studies
- Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerPHASE3 · Recruiting · Canadian Cancer Trials Group · Fairbanks, Alaska
- ATEMPT 2.0: Adjuvant T-DM1 vs THPHASE2 · Recruiting · Dana-Farber Cancer Institute · San Francisco, California
- Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25PHASE3 · Recruiting · NRG Oncology · Birmingham, Alabama
- Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer SurvivorsRecruiting · NRG Oncology · Anchorage, Alaska